The Role and Place of Partially Hydrolysed Protein Infant Formulas in the Nutrition of Full-term Children: Digestive Comfort and Allergy Prevention
https://doi.org/10.15690/vsp.v19i4.2135
Abstract
The continued increase in the number of allergic diseases and the high prevalence of digestive disturbances in infants explain the interest of pediatricians, allergists and gastroenterologists in the development and improvement of nutritional methods for the prevention and correction of these pathologies. This article discusses current ideas on the role of partially hydrolysed protein formulas in infants’ nutrition for recovery of most common functional gastrointestinal disorders, allergy primary prevention. Also, the article discusses formulas place in sequential nutrition therapy of food allergy. Descriptions of cow milk proteins molecular characteristics and its allergens properties are presented. Features of creation and production of partially hydrolysed protein formulas are described as well.
Keywords
formulas,
partially hydrolysed proteins,
infants,
functional illness ,
digestion,
prevention,
allergy,
cow milk protein
Supporting agencies: The article has been funded by Nestle Russia LLC
About the Authors
Nataliia B. Migacheva
Samara State Medical University
Russian Federation
Samara
Disclosure of interest: The other contributors confirmed the absence of a reportable conflict of interests.
Russian Federation
Samara
Disclosure of interest: The other contributors confirmed the absence of a reportable conflict of interests.
Evgeniia M. Mukhametova
Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Moscow
Disclosure of interest: The other contributors confirmed the absence of a reportable conflict of interests.
Russian Federation
Moscow
Disclosure of interest: The other contributors confirmed the absence of a reportable conflict of interests.
Evgeniia G. Makarova
Mechnikov North-Western State Medical University;
Nestle Russia LLC
Russian Federation
Disclosure of interest: Sergey E. Ukraintsev, Evgeniia G. Makarova are employees of Nestle Russia LLC.
Russian Federation
Saint-Petersburg;
Moscow
Disclosure of interest: Sergey E. Ukraintsev, Evgeniia G. Makarova are employees of Nestle Russia LLC.
Sergey E. Ukraintsev
Nestle Russia LLC
Russian Federation
Moscow
Disclosure of interest: Sergey E. Ukraintsev, Evgeniia G. Makarova are employees of Nestle Russia LLC.
Russian Federation
Moscow
Disclosure of interest: Sergey E. Ukraintsev, Evgeniia G. Makarova are employees of Nestle Russia LLC.
References
1. Szajewska H, Horvath A. Meta-analysis of the evidence for a partially hydrolyzed 100% whey formula for the prevention of allergic diseases. Curr Med Res Opin. 2010;26(2):423–437. doi: 10.1185/03007990903510317.
2. Vandenplas Y, Alarcon P, Fleischer D, et al. Should Partial Hydrolysates Be Used as Starter Infant Formula? A Working Group Consensus. J Pediatr Gastroenterol Nutr. 2016;62(1):22–35. doi: 10.1097/MPG.0000000000001014.
3. Hochwallner H, Schulmeister U, Swoboda I, et al. Cow’s milk allergy: from allergens to new forms of diagnosis, therapy and prevention. Methods. 2014;66(1):22–33. doi:10.1016/j.ymeth.2013.08.005.
4. Rueter K, Prescott SL, Palmer DJ. Nutritional approaches for the primary prevention of allergic disease: An update. J Paediatr Child Health. 2015;51(10):962–969; quiz 968–969. doi: 10.1111/jpc.12951.
5. Monaci L, Tregoat V, van Hengel AJ, Anklam E. Milk allergens, their characteristics and their detection in food: A review. Eur Food Res Technol. 2006;223(2):149–179. doi: 10.1007/S00217-005-0178-8.
6. Jost R, Fritsche R, Pahud JJ. Reduction of milk protein allergenicity through processing. Bibl Nutr Dieta. 1991;(48):127–137. doi: 10.1159/000420043.
7. Vandenplas Y, Latiff AHA, Fleischer DM, et al. Partially hydrolyzed formula in non-exclusively breastfed infants: A systematic review and expert consensus. Nutrition. 2019;57:268–274. doi: 10.1016/j.nut.2018.05.018.
8. Bernard H, Creminon C, Yvon M, et al. Specificity of the human IgE response to the different purified caseins in allergy to cow’s milk proteins. Int Arch Allergy Immunol. 1998;115(3):235–244. doi: 10.1159/000023906.
9. Ruiter B, Tregoat V, M’rabet L, et al. Characterization of T cell epitopes in alphas1-casein in cow’s milk allergic, atopic and non-atopic children. Clin Exp Allergy. 2006;36(3):303–310. doi: 10.1111/j.1365-2222.2006.02436.x.
10. Spuergin P, Mueller H, Walter M, et al. Allergenic epitopes of bovine a S1-casein recognized by human IgE and IgG. Allergy. 1996; 51(5):306–312. doi: 10.1111/j.1398-9995.1996.tb04614.x.
11. Restani P, Gaiaschi A, Plebani A, et al. Cross-reactivity between milk proteins from different animal species. Clin Exp Allergy. 1999; 29(7):997–1004. doi: 10.1046/j.1365-2222.1999.00563.x.
12. Rozenfeld P, Docena GH, Anon MC, Fossati CA. Detection and identification of a soy protein component that cross-reacts with caseins from cow’s milk. Clin Exp Immunol. 2002;130(1):49–58. doi: 10.1046/j.1365-2249.2002.t01-1-01935.x.
13. Han GD, Matsuno M, Ito S, et al. Meat allergy: investigation of potential allergenic proteins in beef. Biosci Biotechnol Biochem. 2000;64(9):1887–1895. doi: 10.1271/bbb.64.1887.
14. Vicente-Serrano J, Caballero ML, Rodriguez-Perez R, et al. Sensitization to serum albumins in children allergic to cow’s milk and epithelia. Pediatr Allergy Immunol. 2007;18(6):503–507. doi: 10.1111/j.1399-3038.2007.00548.x.
15. Anderson PJ, Brooks CL, Berliner LJ. Functional identification of calcium binding residues in bovine alpha-lactalbumin. Biochemistry. 1997;36(39):11648–11654. doi: 10.1021/bi9709598.
16. Svensson M, Hakansson A, Mossberg AK, et al. Conversion of alpha-lactalbumin to a protein inducing apoptosis. Proc Natl Acad Sci U S A. 2000;97(8):4221–4226. doi: 10.1073/pnas.97.8.4221.
17. Permyakov EA, Berliner LJ. Alpha-Lactalbumin: structure and function. FEBS Lett. 2000;473(3):269–274. doi: 10.1016/s0014-5793(00)01546-5.
18. Maynard F, Jost R, Wal JM. Human IgE binding capacity of tryptic peptides from bovine alpha-lactalbumin. Int Arch Allergy Immunol. 1997;113(4):478–488. doi: 10.1159/000237625.
19. Suutari TJ, Valkonen KH, Karttunen TJ, et al. IgE cross reactivity between reindeer and bovine milk beta-lactoglobulins in cow’s milk allergic patients. J Investig Allergol Clin Immunol. 2006; 16(5):296–302.
20. Aymard P, Durand D, Nicolai T. The effect of temperature and ionic strength on the dimerisation of beta-lactoglobulin. Int J Biol Macromol. 1996;19(3):213–221. doi: 10.1016/0141-8130(96)01130-0.
21. Adler-Nissen J. Determination of degree of hydrolysis of food protein hydrolysates by trinitrobenzenesulfonic acid. J Agric Food Chem. 1979;27(6):1256–1279. doi: 10.1021/jf60226a042.
22. El-Agamy EI. The challenge of cow milk protein allergy. Small Rumin Res. 2007;68(1–2):64–72. doi: 10.1016/j.smallrumres.2006.09.016.
23. Schmidt DG, Meijer RJ, Slangen CJ, van Beresteijn EC. Raising the pH of the pepsin-catalysed hydrolysis of bovine whey proteins increases the antigenicity of the hydrolysates. Clin Exp Allergy. 1995; 25(10):1007–1017. doi: 10.1111/j.1365-2222.1995.tb00404.x.
24. Ehn B-M, Ekstrand B, Bengtsson U, Ahlstedt S. Modification of IgE-binding during heat processing of the cow’s milk allergen betalactoglobulin. J Agric Food Chem. 2004;52(5):1398–1403. doi: 10.1021/jf0304371.
25. Fritsche R. The role of immune tolerance in allergy prevention. Nestle Nutr Workshop Ser Pediatr Program. 2005;56:1–9; discussion 9–14. doi: 10.1159/000086231.
26. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies). Scientific Opinion on the essential composition of infant and follow-on formulae. EFSA J. 2014;12(7):3760. doi: 10.2903/J.EFSA.2014.3760.
27. Salvatore S, Vandenplas Y. Hydrolyzed Proteins in Allergy. In: Bhatia J, Shamir R, Vandenplas Y, eds. Protein in Neonatal and Infant Nutrition: Recent Updates. Nestle Nutr Inst Workshop Ser. 2016; 86:11–27. doi: 10.1159/000442699.
28. Greer FR, Sicherer SH, Burks AW, et al. Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas. Pediatrics. 2008;121(1):183–191. doi: 10.1542/peds.2007-3022.
29. Vandenplas Y, Bathia J, Shamir R, et al. Hydrolyzed formulas for allergy prevention. J Pediatr Gastroenterol Nutr. 2014;58(5): 549–552. doi: 10.1097/MPG.0000000000000318.
30. Tsabouri S, Douros K, Priftis KN. Cow’s milk allergenicity. Endocr Metab Immune Disord Drug Targets. 2014;14(1):16–26. doi: 10.2174/1871530314666140121144224.
31. Terracciano L, Isoardi P, Arrigoni S, et al. Use of hydrolysates in the treatment of cow’s milk allergy. Ann Allergy Asthma Immunol. 2002;89(6 Suppl 1):86–90. doi: 10.1016/s1081-1206(10)62130-8.
32. Pecquet S, Bovetto L, Maynard F, Fritsche R. Peptides obtained by tryptic hydrolysis of bovine beta-lactoglobulin induce specific oral tolerance in mice. J Allergy Clin Immunol. 2000;105(3):514–521. doi: 10.1067/mai.2000.103049.
33. Lozano-Ojalvo D, Berin C, Tordesillas L. Immune basis of allergic reactions to food. J Investig Allergol Clin Immunol. 2019;29(1): 1–14. doi: 10.18176/jiaci.0355.
34. Kumfer AM, Commins SP. Primary prevention of food allergy. Curr Allergy Asthma Rep. 2019;19(1):7. doi: 10.1007/s11882-019-0838-6.
35. Nowak-Wegrzyn A, Chatchatee P. Mechanisms of tolerance induction. Ann Nutr Metab. 2017;70(Suppl 2):7–24. doi: 10.1159/000457915.
36. Rezende RM, Weiner HL. History and mechanisms of oral tolerance. Semin Immunol. 2017;30:3–11. doi: 10.1016/j.smim.2017.07.004.
37. Smolkin YS, Grishchenko EA. Modern ideas about the formation of oral tolerance. Allergologiya i immunologiya v pediatrii. 2015;43(4):29–35. (In Russ).
38. Berin MC, Sampson HA. Mucosal immunology of food allergy. Curr Biol. 2013;23(9):R389–R400. doi: 10.1016/j.cub.2013.02.043.
39. Tanoue T, Atarashi K, Honda K. Development and maintenance of intestinal regulatory T cells. Nat Rev Immunol. 2016;16(5): 295–309. doi: 10.1038/nri.2016.36.
40. Hadis U, Wahl B, Schulz O, et al. Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria. Immunity. 2011;34(2):237–246. doi: 10.1016/j.immuni.2011.01.016.
41. Torgerson TR, Linane A, Moes N, et al. Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene. Gastroenterology. 2007;132(5):1705–1717. doi: 10.1053/j.gastro.2007.02.044.
42. Jaensson E, Uronen-Hansson H, Pabst O, et al. Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans. J Exp Med. 2008; 205(9):2139–2149. doi: 10.1084/jem.20080414.
43. Klebanoff CA, Spencer SP, Torabi-Parizi P, et al. Retinoic acid controls the homeostasis of precDC-derived splenic and intestinal dendritic cells. J Exp Med. 2013;210(10):1961–1976. doi: 10.1084/jem.20122508.
44. Tsuji NM, Kosaka A. Oral tolerance: intestinal homeostasis and antigen-specific regulatory T cells. Trends Immunol. 2008;29(11): 532–540. doi: 10.1016/j.it.2008.09.002.
45. Ukraintsev SY. Prevention of Allergy: From Immunology of Pregnancy To Infant Feeding in the First Months of Life. Voprosy sovremennoi pediatrii — Current Pediatrics. 2016;15(6):604–609. (In Russ). doi.org/10.15690/vsp.v15i6.1658.
46. Wang Y, Allen KJ, Koplin JJ. Dietary intervention for preventing food allergy in children. Curr Opin Pediatr. 2017;29(6):704–710. doi: 10.1097/MOP.0000000000000552.
47. Grulee C, Sanford H. The influence of breast and artificial feeding on infantile eczema. J Pediatr. 1936;9(2):223–225. doi: 10.1016/S0022-3476(36)80058-4.
48. Lucas A, Brooke O, Morley R, et al. Early diet of preterm infants and development of allergic or atopic disease: randomized prospective study. BMJ. 1990;300(6728):837–840. doi: 10.1136/bmj.300.6728.837.
49. Gdalevich M, Mimouni D, David M. Breastfeeding and the onset of atopic dermatitis in childhood: a systematic review and metaanalysis of prospective studies. J Am Acad Dermatol. 2001;45(4): 520–527. doi: 10.1067/mjd.2001.114741.
50. Von Berg A, Koletzko S, Filipiak-Pittroff B, et al. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three-year results of the German Infant Nutritional Intervention Study. J Allergy Clin Immunol. 2007;119(3): 18–25. doi: 10.1016/j.jaci.2006.11.017.
51. Von Berg A, Filipiak-Pittroff B, Kramer U, et al. Allergies in highrisk schoolchildren after early intervention with cow’s milk protein hydrolysates: 10-year results from the German Infant Nutritional Intervention (GINI) study. J Allergy Clin Immunol. 2013;131(6): 1565–1573. doi: 10.1016/j.jaci.2013.01.006.
52. Osborn DA, Sinn J. Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants. Cochrane Database Syst Rev. 2006;18(4):CD003664. doi: 10.1002/14651858.CD003664.pub3.
53. Szajewska H, Horvath A. A partially hydrolyzed 100% whey formula and the risk of eczema and any allergy: an updated metaanalysis. World Allergy Organ J. 2017;26;10(1):27. doi: 10.1186/s40413-017-0158-z.
54. Von Berg A, Filipiak-Pittroff B, Schulz H, et al. Allergic manifestation 15 years after early intervention with hydrolyzed formulas — the GINI Study. Allergy. 2016;71(2):210–219. doi: 10.1111/all.12790.
55. Spieldenner J, Belli D, Dupont C, et al. Partially hydrolysed 100% whey-based infant formula and the prevention of atopic dermatitis: comparative pharmacoeconomic analyses. Ann Nutr Metab. 2011;59(Suppl 1):44–52. doi: 10.1159/000334232.
56. Botteman MF, Bhanegaonkar AJ, Horodniceanu EG, et al. Economic value of using partially hydrolysed infant formula for risk reduction of atopic dermatitis in high-risk, not exclusively breastfed infants in Singapore. Singapore Med J. 2018;59(8):439–448. doi: 10.11622/smedj.2017113.
57. Namazova-Baranova LS, 2, Makarova SG, Novik GA, Vishneva EA. National practical guidelines for management of cow’s milk protein allergy in infants and children. Brief overview. Rossiiskii allergologicheskii zhurnal. 2017;14(2):55–65. (In Russ).
58. Pervichnaya profilaktika allergii u detei. Soglasitel’nyi dokument Assotsiatsii detskikh allergologov i immunologov Rossii. Moscow; 2010. (In Russ).
59. Wood RA, Sicherer SH, Vickery BP, et al. The natural history of milk allergy in an observational cohort. J Allergy Clin Immunol. 2013; 131(3):805–812. doi: 10.1016/j.jaci.2012.10.060.
60. Elizur A, Rajuan N, Goldberg MR, et al. Natural course and risk factors for persistence of IgE-mediated cow’s milk allergy. J Pediatr. 2012;161(3):482–487.e1. doi: 10.1016/j.jpeds.2012.02.028.
61. Sackesen C, Altintas DU, Bingol A, et al. Current Trends in Tolerance Induction in Cow’s Milk Allergy: From Passive to Proactive Strategies. Front Pediatr. 2019;7:372. doi: 10.3389/fped.2019.00372.
62. Fiocchi A, Brozek J, Schunemann H, et al. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow’s Milk Allergy (DRACMA) Guidelines. Pediatr Allergy Immunol. 2010; 21(Suppl 21):1–125. doi: 10.1111/j.1399-3038.2010.01068.x.
63. Vandenplas Y. Prevention and Management of Cow’s Milk Allergy in Non-Exclusively Breastfed Infants. Nutrients. 2017;9(7):731. doi: 10.3390/nu9070731.
64. Luyt D, Ball H, Makwana N, et al. BSACI guideline for the diagnosis and management of cow’s milk allergy. Clin Exp Allergy. 2014;44(5):642–672. doi: 10.1111/cea.12302.
65. Brozek JL, Terracciano L, Hsu J, et al. Oral immunotherapy for IgE-mediated cow’s milk allergy: a systematic review and meta-analysis. Clin Exp Allergy. 2012;42(3):363–374. doi: 10.1111/j.1365-2222.2011.03948.x.
66. D’Auria E, Salvatore S, Pozzi E, et al. Cow’s Milk Allergy: Immunomodulation by Dietary Intervention. Nutrients. 2019;11(6): 1399. doi: 10.3390/nu11061399.
67. Berni Canani R, Nocerino R, Terrin G, et al. Formula selection for management of children with cow’s milk allergy influences the rate of acquisition of tolerance: a prospective multicenter study. J Pediatr. 2013;163(3):771–777. doi: 10.1016/j.jpeds.2013.03.008.
68. Kim AR, Kim HS, Nam ST, et al. Mesenteric IL-10-producing CD5+ regulatory B cells suppress cow’s milk casein-induced allergic responses in mice. Sci Rep. 2016;6:19685. doi: 10.1038/srep19685.
69. Kiewiet MBG, Dekkers R, Gros M, et al. Toll-like receptor mediated activation is possibly involved in immunoregulating properties of cow’s milk hydrolysates. PLoS One. 2017;12(6): e0178191. doi: 10.1371/journal.pone.0178191.
70. Inuo C, Tanaka K, Suzuki S, et al. Oral Immunotherapy Using Partially Hydrolyzed Formula for Cow’s Milk Protein Allergy: A Randomized, Controlled Trial. Int Arch Allergy Immunol. 2018; 177(3):259–268. doi: 10.1159/000490804.
71. Inuo C, Tanaka K, Nakajima Y, et al. Tolerability of partially and extensively hydrolysed milk formulas in children with cow’s milk allergy. Asia Pac J Clin Nutr. 2019;28(1):49–56. doi: 10.6133/apjcn.201903_28(1).0008.
72. Astier C, Morisset M, Roitel O, et al. Predictive value of skin prick tests using recombinant allergens for diagnosis of peanut allergy. J Allergy Clin Immunol. 2006;118:250–256. doi: 10.1016/j.jaci.2006.04.053.
73. Vandenplas Y, Al-Hussaini B, Al-Mannaei K, et al. Prevention of Allergic Sensitization and Treatment of Cow’s Milk Protein Allergy in Early Life: The Middle-East Step-Down Consensus. Nutrients. 2019;11(7).1444. doi: 10.3390/nu11071444.
74. Vandenplas Y, Benninga M, Broekaert I, et al. Functional gastrointestinal disorder algorithms focus on early recognition, parental reassurance and nutritional strategies [published correction appears in Acta Paediatr. 2016;105(8):984]. Acta Paediatr. 2016; 105(3):244–252. doi:10.1111/apa.13270.
75. Rosen R, Vandenplas Y, Singendonk M, et al. Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recom mendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2018;66(3):516–554. doi: 10.1097/MPG.0000000000001889.
76. Vandenplas Y, Hauser B, Salvatore S. Functional Gastrointestinal Disorders in Infancy: Impact on the Health of the Infant and Family. Pediatr Gastroenterol Hepatol Nutr. 2019;22(3):207–216. doi: 10.5223/pghn.2019.22.3.207.
77. Salvatore S, Abkari A, Cai W, et al. Review shows that parental reassurance and nutritional advice help to optimise the management of functional gastrointestinal disorders in infants. Acta Paediatr. 2018;107(9):1512–1520. doi: 10.1111/apa.14378.
78. Salvatore S, Savino F, Singendonk M, et al. Thickened infant formula: What to know. Nutrition. 2018; 49:51–56. doi: 10.1016/j.nut.2017.10.010.
79. Vandenplas Y, Leluyer B, Cazaubiel M, et al. Double-blind comparative trial with two antiregurgitation formulae. J Pediatr Gastroenterol Nutr. 2013;57(3):389–393. doi: 10.1097/MPG.0b013e318299993e.
80. Indrio F, Riezzo G, Giordano P, et al. Effect of a Partially Hydrolysed Whey Infant Formula Supplemented with Starch and Lactobacillus reuteri DSM 17938 on Regurgitation and Gastric Motility. Nutrients. 2017;9(11):1181. doi: 10.3390/nu9111181.
81. Gonzalez-Bermudez CA, Frontela-Saseta C, Lopez-Nicolas R, et al. Effect of adding different thickening agents on the viscosity properties and in vitro mineral availability of infant formula. Food Chem. 2014;159:5–11. doi: 10.1016/j.foodchem.2014.02.168.
82. Horvath A, Dziechciarz P, Szajewska H. The effect of thickened feed interventions on gastroesophageal reflux in infants: systematic review and meta-analysis of randomized, controlled trials. Pediatrics. 2008;122(6):e1268–1277. doi: 10.1542/peds.2008-1900.
83. Makarova EG, Klepikova TV, Ukraintsev SE. Minimal Gastrointestinal Disorders in Infants: When It Is Too Early to Treat. Voprosy sovremennoi pediatrii — Current Pediatrics. 2019;18(4):247–256. (In Russ). doi: 10.15690/vsp.v18i4.2041.
84. Gutierrez-Castrellon P, Indrio F, Bolio-Galvis A, et al. Efficacy of Lactobacillus reuteri DSM 17938 for infantile colic: Systematic review with network meta-analysis. Medicine (Baltimore). 2017; 96(51):e9375. doi: 10.1097/MD.0000000000009375.
85. Salanti G, Ades AE, Ioannidis JP. Graphical methods and numerical summaries for presenting results from multiple-treatment metaanalysis: an overview and tutorial. J Clin Epidemiol. 2011;64(2): 163–171. doi: 10.1016/j.jclinepi.2010.03.016.
86. Krasavina NA, Kabanova NK, Perminova OA, et al. The possibilities of dietetic management of mixed forms of functional digestive disorders in infants in their first year of life: results of clinical testing of a new product in an open comparative prospective study. Voprosy detskoi dietologii. 2017;15(6):18–24. (In Russ). doi: 10.20953/1727-5784-2017-6-18-24.
87. Tabbers MM, Di Lorenzo C, Berger MY, et al. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr. 2014;58(2):265–281. doi: 10.1097/MPG.0000000000000266.
88. Czerkies LA, Kineman BD, Cohen SS, et al. A Pooled Analysis of Growth and Tolerance of Infants Exclusively Fed Partially Hydrolyzed Whey or Intact Protein-Based Infant Formulas. Int J Pediatr. 2018; 2018:4969576. doi: 10.1155/2018/4969576.
89. Vandenplas Y, Munasir Z, Hegar B, et al. A perspective on partially hydrolyzed protein infant formula in nonexclusively breastfed infants. Korean J Pediatr. 2019;62(5):149–154. doi: 10.3345/kjp.2018.07276.
Review
For citations:
Migacheva N.B., Mukhametova E.M., Makarova E.G., Ukraintsev S.E. The Role and Place of Partially Hydrolysed Protein Infant Formulas in the Nutrition of Full-term Children: Digestive Comfort and Allergy Prevention. Current Pediatrics. 2020;19(4):279-290. (In Russ.) https://doi.org/10.15690/vsp.v19i4.2135
Views:
1184
Email this article 
